We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

U.S. Competition Watchdog Decries Drug Deals

Law360 (January 17, 2007, 12:00 AM EST) -- As Congress hears arguments on so-called authorized generics, a new report by the Federal Trade Commission reveals what the antitrust watchdog calls a worrisome rise in cozy deals between generic and brand drug makers.

While the head of the world’s largest generic pharmaceutical manufacturers testified Wednesday before a senate committee in defense of rival company agreements, the Federal Trade Commission said the deals cheated consumers out of billions of dollars in savings on cheap drugs.

A study released Wednesday by the FTC shows the number of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.